9 October 2024 false No description of principal activity Taxfiler 2024.6 16008045business:PrivateLimitedCompanyLtd2024-10-092025-10-31 160080452024-10-08 160080452024-10-092025-10-31 16008045business:AuditExempt-NoAccountantsReport2024-10-092025-10-31 16008045business:FilletedAccounts2024-10-092025-10-31 160080452025-10-31 16008045business:Director12024-10-092025-10-31 16008045business:Director22024-10-092025-10-31 16008045business:RegisteredOffice2024-10-092025-10-31 16008045core:WithinOneYear2025-10-31 16008045core:ShareCapitalcore:PreviouslyStatedAmount2025-10-31 16008045core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-10-31 16008045core:PreviouslyStatedAmount2025-10-31 16008045business:SmallEntities2024-10-092025-10-31 16008045countries:EnglandWales2024-10-092025-10-31 16008045business:OrdinaryShareClass12024-10-092025-10-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 16008045 (England and Wales)
Alphacaremax Ltd Unaudited accounts for the period from 9 October 2024 to 31 October 2025
Alphacaremax Ltd Unaudited accounts Contents
Page
- 2 -
Alphacaremax Ltd Company Information for the period from 9 October 2024 to 31 October 2025
Directors
Mr Mohamed Ahmed Mohamed Hengel Mr Amr Mohamed Nagib Abdel Fattah Esawi Heweit
Company Number
16008045 (England and Wales)
Registered Office
112 Lougborough House 2 Honour Gardens London RM8 2GJ United Kingdom
Accountants
Fabaci Financial Ltd 30 Ebbett Court Victoria Road London W3 6BW
- 3 -
Alphacaremax Ltd Statement of financial position as at 31 October 2025
2025 
Notes
£ 
Creditors: amounts falling due within one year
(470)
Net current liabilities
(470)
Net liabilities
(470)
Capital and reserves
Called up share capital
100 
Profit and loss account
(570)
Shareholders' funds
(470)
For the period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 9 October 2026 and were signed on its behalf by
Mr Mohamed Ahmed Mohamed Hengel Director Company Registration No. 16008045
- 4 -
Alphacaremax Ltd Notes to the Accounts for the period from 9 October 2024 to 31 October 2025
1
Statutory information
Alphacaremax Ltd is a private company, limited by shares, registered in England and Wales, registration number 16008045. The registered office is 112 Lougborough House, 2 Honour Gardens, London, RM8 2GJ, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard. The company was incorporated on 9 October 2024.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in GBP sterling.
Foreign exchange
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.
4
Creditors: amounts falling due within one year
2025 
£ 
Loans from directors
470 
5
Share capital
2025 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
Shares issued during the period:
100 Ordinary shares of £1 each
100 
6
Average number of employees
During the period the average number of employees was 2.
- 5 -